Cargando…
Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008583/ https://www.ncbi.nlm.nih.gov/pubmed/32103940 http://dx.doi.org/10.2147/IJN.S247761 |
Ejemplares similares
-
Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy
por: Tahir, Nayab, et al.
Publicado: (2019) -
Association of venous thromboembolism between hydrophilic and lipophilic statin users among diabetic subjects: Erratum
Publicado: (2022) -
Polymer–lipid hybrid nanoparticles as potential lipophilic anticancer drug carriers
por: Salel, Sedef, et al.
Publicado: (2023) -
Hydrophilic or Lipophilic Statins?
por: Climent, Elisenda, et al.
Publicado: (2021) -
MRI-guided targeting delivery of doxorubicin with reduction-responsive lipid-polymer hybrid nanoparticles
por: Wu, Bo, et al.
Publicado: (2017)